A carregar...
Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
Antibodies against inhibitory immune checkpoint molecules (ICPMs), referred to as immune checkpoint inhibitors (ICIs), have gained a prominent place in cancer therapy. Several ICIs in clinical use have been engineered to be devoid of effector functions because of the fear that ICIs with preserved ef...
Na minha lista:
| Publicado no: | Cells |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8069236/ https://ncbi.nlm.nih.gov/pubmed/33921301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10040872 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|